Eton Pharmaceuticals Inc., of Deer Park, Ill., is selling 3 million shares at $6 per share in its IPO. The specialty pharmaceutical company is focused on developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway. The company will list its shares on Nasdaq under the symbol ETON.